Literature DB >> 21524256

Role of PACAP in neural stem/progenitor cell and astrocyte--from neural development to neural repair.

Tomoya Nakamachi1, Jozsef Farkas, Jun Watanabe, Hirokazu Ohtaki, Kenji Dohi, Satoru Arata, Seiji Shioda.   

Abstract

After central nervous system (CNS) injury, reactive astrocytes display opposing functions, inducing neural repair and axonal regeneration via the release of growth factors, or forming a glial scar which acts as a barrier to axonal regeneration. Endogenous neural stem/progenitor cells have also recently been identified at the site of CNS injury, where they have been shown to differentiate into mature neurons in an animal model of ischemia. However, the pathophysiological mechanisms underpinning the contribution of reactive astrocytes and neural stem/progenitor cells to neural repair are still to be fully elucidated. Pituitary adenylate cyclase activating polypeptide (PACAP) is widely expressed in the CNS, where it has been shown to exert numerous biological effects. This review will summarize the current state of knowledge regarding the expression of PACAP and its receptors during neural development, as well as the involvement of PACAP in astrocytes and neural stem/progenitor cell biology. In addition, we will also discuss emerging evidence that implicates PACAP in neurogenesis and neural repair in response to brain pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21524256     DOI: 10.2174/138161211795589346

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  22 in total

1.  IL-6 and PACAP receptor expression and localization after global brain ischemia in mice.

Authors:  Tomoya Nakamachi; Masashi Tsuchida; Nobuyuki Kagami; Sachiko Yofu; Yoshihiro Wada; Motohide Hori; Daisuke Tsuchikawa; Akira Yoshikawa; Nori Imai; Keisuke Nakamura; Satoru Arata; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2012-06-06       Impact factor: 3.444

2.  Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Is Involved in Adult Mouse Hippocampal Neurogenesis After Stroke.

Authors:  Minako Matsumoto; Tomoya Nakamachi; Jun Watanabe; Koichi Sugiyama; Hirokazu Ohtaki; Norimitsu Murai; Shun Sasaki; Zhifang Xu; Hitoshi Hashimoto; Tamotsu Seki; Akira Miyazaki; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2016-02-24       Impact factor: 3.444

3.  Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.

Authors:  A Tamas; K Szabadfi; A Nemeth; B Fulop; P Kiss; T Atlasz; R Gabriel; H Hashimoto; A Baba; N Shintani; Zs Helyes; D Reglodi
Journal:  Neurotox Res       Date:  2011-12-28       Impact factor: 3.911

4.  Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.

Authors:  K Szabadfi; T Atlasz; P Kiss; B Danyadi; A Tamas; Zs Helyes; H Hashimoto; N Shintani; A Baba; G Toth; R Gabriel; D Reglodi
Journal:  Neurotox Res       Date:  2011-06-30       Impact factor: 3.911

5.  Examination of calcium-binding protein expression in the inner ear of wild-type, heterozygous and homozygous pituitary adenylate cyclase-activating polypeptide (PACAP)-knockout mice in kanamycin-induced ototoxicity.

Authors:  A Nemeth; K Szabadfi; B Fulop; D Reglodi; P Kiss; J Farkas; B Szalontai; R Gabriel; H Hashimoto; A Tamas
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

6.  PACAP is an endogenous protective factor-insights from PACAP-deficient mice.

Authors:  D Reglodi; P Kiss; K Szabadfi; T Atlasz; R Gabriel; G Horvath; P Szakaly; B Sandor; A Lubics; E Laszlo; J Farkas; A Matkovits; R Brubel; H Hashimoto; A Ferencz; A Vincze; Z Helyes; L Welke; A Lakatos; A Tamas
Journal:  J Mol Neurosci       Date:  2012-04-14       Impact factor: 3.444

7.  Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist.

Authors:  Yukio Ago; Michael C Condro; Yossan-Var Tan; Cristina A Ghiani; Christopher S Colwell; Jesse D Cushman; Michael S Fanselow; Hitoshi Hashimoto; James A Waschek
Journal:  Psychopharmacology (Berl)       Date:  2015-01-11       Impact factor: 4.530

8.  Neuroprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on spinal cord injury.

Authors:  Daisuke Tsuchikawa; Tomoya Nakamachi; Masashi Tsuchida; Yoshihiro Wada; Motohide Hori; Jozsef Farkas; Akira Yoshikawa; Nobuyuki Kagami; Nori Imai; Norihito Shintani; Hitoshi Hashimoto; Takashi Atsumi; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2012-06-07       Impact factor: 3.444

9.  Comparison of expression and proliferative effect of pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors on human astrocytoma cell lines.

Authors:  Tomoya Nakamachi; Kouichi Sugiyama; Jun Watanabe; Nori Imai; Nobuyuki Kagami; Motohide Hori; Satoru Arata; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2014-08-06       Impact factor: 3.444

Review 10.  VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair.

Authors:  J A Waschek
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.